Back to BNP Paribas Financial Markets BNP Paribas Financial Markets

MRNAMRNA

Showing 8 of 29 quarters

Position history for BNP Paribas Financial MarketsBNP Paribas Financial Markets's holdings in Moderna, Inc.

Yes. BNP Paribas Financial Markets holds 4,377,120 shares of MRNA (Moderna), worth $306.5M, as of its Q2 2026 13F filing. It increased the position by 59,901 shares (+1.4%) from Q1 2026. BNP Paribas Financial Markets has held MRNA since Q2 2019, across 29 quarterly 13F filings. MRNA is 0.1% of BNP Paribas Financial Markets' reported 13F portfolio.

Current Value

$306.5M

Current Shares

4.4M

Total Value Change

+$224.7M

Total Shares Change

+3.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.4M
+1.4%
$306.5M0.1%$70.03
37
2026-Q1
Increased
4.3M
+4.0%
$219.3M0.1%$50.80
38
2025-Q4
Increased
4.2M
+279.7%
$122.5M0.1%$29.49
49
2025-Q3
Decreased
1.1M
-10.7%
$28.2M0.0%$25.83
0
2025-Q2
Decreased
1.2M
-15.4%
$33.8M0.0%$27.59
0
2025-Q1
Increased
1.4M
+17.0%
$41.1M0.0%$28.35
34
2024-Q4
Increased
1.2M
+1.1%
$51.5M0.0%$41.58
30
2024-Q3
Increased
1.2M
+65.8%
$81.8M0.1%$65.75
44

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used